P3 Health PartnersNASDAQ: PIII

P3 Health Partners (NASDAQ: PIII ) stock is falling on Tuesday after the company sold shares and warrants to institutional investors in a recent offering. P3 Health Partners reveals in a filing with the Securities and Exchange Commission (SEC) that it issued roughly 67.4 million shares of PIII stock to institutional investors.

P3 Health Partners (PIII) lacks the necessary elements for a potential earnings surprise in its upcoming report. Be ready with the key projections.

P3 Health Partners Inc. (PIII) Q4 2023 Earnings Call Transcript

P3 Health Partners shares jumped in Wednesday premarket trading after the healthcare company guided for a strong rise in 2024 revenue and positive underlying earnings (EBITDA) as it grows its Medicare Advantage member base. In an update ahead of a presentation at a J.P.

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that it will participate at the upcoming J.P. Morgan Healthcare Conference in San Francisco, California. Management will give a presentation on Wednesday, January 10, 2024, at 1:30 PM Pacific Time. A webcast of the live event will be available on the P3 Investor Relations website at ir.p3hp.org. A replay will be available shortly a.

P3 Health Partners Inc. (NASDAQ:PIII ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Corporate Participants Karen Blomquist - Vice President, Investor Relations Sherif Abdou - Chief Executive Officer & Co-Founder Bill Bettermann - Chief Operating Officer Atul Kavthekar - Chief Financial Officer Amir Bacchus - Chief Medical Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Josh Raskin - Nephron Research Gary Taylor - TD Cowen Ryan Daniels - William Blair Jenny Shen - BTIG Operator Good afternoon, everyone, and welcome to the P3 Health Partners Third Quarter Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for third-quarter 2023 and file its Quarterly Report on Form 10-Q on Wednesday, November 8, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update: Title & Webcast P3 Health Thi.

P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Karen Blomquist - Vice President, Investor Relations Sherif Abdou - Chief Executive Officer & Co-Founder Bill Bettermann - Chief Operating Officer Atul Kavthekar - Chief Financial Officer Amir Bacchus - Chief Medical Officer Conference Call Participants Joshua Raskin - Nephron Research Ryan Daniels - William Blair Gary Taylor - TD Cowen Brooks O'Neil - Lake Street Capital Markets Operator Hello, and welcome to the P3 Health Partners Q2 2023 Earnings Call. [Operator Instructions] Please note, today's event is being recorded.

One of the best-performing stocks this month is a company you might have never heard of. Shares of P3 Health Partners NASDAQ: PIII are up 182% so far in May, but a recent trendline break and volume decrease could signal a character shift.